Essilorluxottica Sa has released a press release.
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
Earlier from Essilorluxottica Sa
- EssilorLuxottica: Déclaration de transactions sur actions propres
- EssilorLuxottica: 24-Month U.S. Clinical Trial Results Supporting FDA De Novo Market Authorization of Essilor Stellest Lenses* Published in JAMA Ophthalmology